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Vinblastine (Vb) is an antitumor drug that inhibits microtubule polymerization, 
causes G2/M arrest and induces cell death. 2D-PAGE and MALDI-ToF-MS analysis on 
A549 cells, revealed that vinblastine upregulates an acidic form of the protein Annexin 
A2. The staining of this Vb induced form of Annexin A2 with the phosphospecific dye 
Pro-Q Diamond, indicates the presence of phosphorylated Annexin A2 in this spot. 
Moreover, this Vb up-regulated form of Annexin A2 disappears upon treatment with 
λ-protein phosphatase, confirming this post-translational modification. Further analysis 
using MRM (multiple reaction monitoring) indicated the presence of a phosphorylated 
peptide, containing threonine 19, serine 18 or serine 22, only in the vincristine 
upregulated form. MS/MS spectra show a clear phosphorylation of Thr19 and lower 
signals for Ser18 and Ser22. These results indicate that phosphorylation of Annexin A2 
in different residues may play a role in the cellular response to Vinblastine.
